Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study.

MLA

Kim, Rathana, et al. “Genetic Alterations and MRD Refine Risk Assessment for KMT2A-Rearranged B-Cell Precursor ALL in Adults: A GRAALL Study.” Blood, vol. 142, no. 21, Nov. 2023, pp. 1806–17. EBSCOhost, https://doi.org/10.1182/blood.2023021501.

APA

Kim, R., Bergugnat, H., Pastoret, C., Pasquier, F., Raffoux, E., Larcher, L., Passet, M., Grardel, N., Delabesse, E., Kubetzko, S., Caye-Eude, A., Meyer, C., Marschalek, R., Lafage-Pochitaloff, M., Thiebaut-Bertrand, A., Balsat, M., Escoffre-Barbe, M., Blum, S., Baumann, M., … Clappier, E. (2023). Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study. Blood, 142(21), 1806–1817. https://doi.org/10.1182/blood.2023021501

Chicago

Kim, Rathana, Hugo Bergugnat, Cédric Pastoret, Florence Pasquier, Emmanuel Raffoux, Lise Larcher, Marie Passet, et al. 2023. “Genetic Alterations and MRD Refine Risk Assessment for KMT2A-Rearranged B-Cell Precursor ALL in Adults: A GRAALL Study.” Blood 142 (21): 1806–17. doi:10.1182/blood.2023021501.